𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticancer activities of histone deacetylase inhibitors

✍ Scribed by Bolden, Jessica E.; Peart, Melissa J.; Johnstone, Ricky W.


Book ID
109950142
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
552 KB
Volume
5
Category
Article
ISSN
1474-1776

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Histone Deacetylase Inhibitors
✍ Thomas A. Miller; David J. Witter; Sandro Belvedere πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons βš– 53 KB
Histone deacetylase inhibitors: Understa
✍ Ana Villar-Garea; Manel Esteller πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 346 KB

## Abstract Cancer is as much an epigenetic disease as it is a genetic and cytogenetic disease. The discovery that drastic changes in DNA methylation and histone modifications are commonly found in human tumors has inspired various laboratories and pharmaceutical companies to develop and study epig

Prospects: Histone deacetylase inhibitor
✍ Milos Dokmanovic; Paul A. Marks πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 160 KB

## Abstract Histone deacetylase (HDAC), inhibitors represent a new class of targeted anti‐cancer agents. Several of these compounds are in clinical trials with significant activity against a spectrum of both hematologic and solid tumors at doses that are well tolerated by the patients. The HDAC inh

Regulation of histone deacetylase activi
✍ Nilanjan Sengupta; Edward Seto πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 141 KB

## Abstract Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from lysine residues in both histone and non‐histone proteins. They play a key role in the regulation of gene transcription and many other biological processes involving chromatin. Significantly, recent